Comparing Palantir and UiPath in the AI Market
Palantir is certainly expanding rapidly, and meanwhile, its reputation is garnering more attention.
UiPath, on the other hand, is facing significant hurdles in the near future, although its stock does seem to be priced attractively.
Both companies represent risky investments in today’s unpredictable market, but there’s a clear distinction in terms of safety.
Palantir (NASDAQ:PLTR) and UiPath (NYSE:PASS) are both set to gain from the long-term growth of the artificial intelligence (A.I.) sector. Palantir specializes in aggregating and analyzing vast amounts of data for government and large enterprise clients. In comparison, UiPath focuses on creating software robots that streamline repetitive tasks in large organizations.
I took a closer look at these two AI stocks back in October of last year, and concluded that Palantir’s robust growth, larger scale, and rising profits made it a more attractive option than UiPath. Since we last discussed this, Palantir’s stock has surged over 340%, while UiPath has had a modest increase of about 13%. It’s worth revisiting both firms to see how Palantir is faring in the AI landscape.
Palantir operates two main platforms: Gotham, which targets government clients, and Foundry for commercial enterprises. Both platforms allow clients to aggregate data from various sources to spot trends and make better decisions. Gotham is already well-established within U.S. governmental operations, playing a significant role in military and law enforcement, and it’s leveraging that to promote Foundry to more business clients.
Integrating UiPath’s robotic process automation (RPA) into an organization’s software can help automate tasks like customer onboarding, data entry, invoice processing, or mass emails. The company also employs AI services to analyze data processed by these robotic tools. Remarkably, UiPath is now the largest RPA provider globally.
In the last fiscal year, Palantir’s revenue was double that of UiPath’s. Moreover, Palantir has been consistently profitable based on generally accepted accounting principles (GAAP) since 2023, while UiPath is projected to achieve its first GAAP profit in fiscal 2026.
From 2020 to 2024, Palantir’s revenue grew from $1.1 billion to $2.9 billion, reflecting a compound annual growth rate (CAGR) of 27%. Through careful spending management, its GAAP net income doubled in 2024.
Sales growth dipped in 2022 and 2023, influenced by increased government expenditure and challenging macroeconomic conditions affecting commercial operations. However, growth resumed in 2024 and is expected to further accelerate in 2025 as military conflicts spurred government clients to invest more in data processing services, while a stabilized macro environment encouraged additional business customers.
Analysts predict that Palantir’s revenue and GAAP earnings per share (EPS) will increase at a CAGR of around 41% and 37%, respectively, from 2024 to 2027. This considerable growth may be driven by its expanding U.S. commercial operations, new contracts with the Defense Department, and international growth. The ongoing AI boom is likely to push more organizations towards data aggregation platforms that bolster modern AI applications.
On the flip side, UiPath is seeing slower revenue growth, with a CAGR of 24% expected from FY 2021 to FY 2025, moving from $608 million to $1.4 billion, while GAAP losses are gradually narrowing. Yet, sales growth slowed considerably in the last three fiscal years, with the most recent increase clocking in at just 9%. The company attributes this slowdown to a challenging macro environment with companies cutting back on software spending, compounded by increased competition from new generative AI tools that can automate many similar tasks.
Some analysts are concerned that these generative AI offerings might render UiPath’s traditional RPA tools outdated, while others believe those tools will adapt and stay relevant as they help analyze more complex data.
As UiPath matures, analysts forecast a modest revenue growth rate of about 9% from FY 2025 to FY 2028. They expect cost-cutting measures will allow the company to achieve GAAP profitability in fiscal 2026, with GAAP EPS projected to rise at a CAGR of 72 over the next two years.
Clearly, Palantir appears stronger overall, but its stock is currently priced at a staggering 83 times next year’s projected sales, which poses a risk for significant price drops during a market downturn. UiPath, conversely, is priced at a much more reasonable 5 times next year’s sales, although it faces near-term challenges as the AI sector evolves. At this moment, I’m not rushing to invest in either stock. If I had to choose, I’d lean toward UiPath for now, as Palantir feels a bit cumbersome.
As you consider investing in Palantir Technologies, it’s wise to weigh all aspects carefully.





